The Canadian market for Alimentary Tract and Metabolism Medicines is projected to show significant growth from 2024 onwards, starting at $164.2 USD per capita and expected to reach $217.8 by 2028. This demonstrates an average annual growth rate (CAGR) of approximately 7.8% over this five-year period. With year-on-year growth rates ranging from 8% to 7% annually, the sector evidences a steady upward trend. The data does not provide specific figures for 2023, but the robust forecast accentuates a positive trajectory.

Future trends to watch:

Advancements in personalized medicine are expected to drive further growth in this sector.
Regulatory changes may impact pricing and market access.
Increasing focus on preventive care could shift demand towards integrated healthcare solutions.